Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1984 1
1985 1
1986 2
1987 4
1988 2
1989 1
1990 1
1991 5
1992 1
1993 4
1994 1
1995 3
1996 7
1997 12
1998 10
1999 23
2000 15
2001 8
2002 8
2003 10
2004 9
2005 1
2006 3
2007 2
2008 2
2010 2
2011 2
2012 1
2013 1
2015 1
2018 1
2020 1
2022 5
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

150 results

Results by year

Filters applied: . Clear all
Page 1
Therapeutic Exploitation of Viral Interference.
Kovesdi I, Bakacs T. Kovesdi I, et al. Infect Disord Drug Targets. 2020;20(4):423-432. doi: 10.2174/1871526519666190405140858. Infect Disord Drug Targets. 2020. PMID: 30950360 Review.
Adenoviral producer cells.
Kovesdi I, Hedley SJ. Kovesdi I, et al. Viruses. 2010 Aug;2(8):1681-1703. doi: 10.3390/v2081681. Epub 2010 Aug 16. Viruses. 2010. PMID: 21994701 Free PMC article.
Structure -activity relationships of PDE5 inhibitors.
Eros D, Szántai-Kis C, Kiss R, Kéri G, Hegymegi-Barakonyi B, Kövesdi I, Orfi L. Eros D, et al. Among authors: kovesdi i. Curr Med Chem. 2008;15(16):1570-85. doi: 10.2174/092986708784911524. Curr Med Chem. 2008. PMID: 18673225 Review.
Adenoviral vectors for gene transfer.
Kovesdi I, Brough DE, Bruder JT, Wickham TJ. Kovesdi I, et al. Curr Opin Biotechnol. 1997 Oct;8(5):583-9. doi: 10.1016/s0958-1669(97)80033-x. Curr Opin Biotechnol. 1997. PMID: 9353227 Review.
Transactivation by the adenovirus E1A gene.
Nevins JR, Raychaudhuri P, Yee AS, Rooney RJ, Kovesdi I, Reichel R. Nevins JR, et al. Among authors: kovesdi i. Biochem Cell Biol. 1988 Jun;66(6):578-83. doi: 10.1139/o88-068. Biochem Cell Biol. 1988. PMID: 3048331 Review.
Gene therapy for collateral vessel development.
Melillo G, Scoccianti M, Kovesdi I, Safi J Jr, Riccioni T, Capogrossi MC. Melillo G, et al. Among authors: kovesdi i. Cardiovasc Res. 1997 Sep;35(3):480-9. doi: 10.1016/s0008-6363(97)00167-3. Cardiovasc Res. 1997. PMID: 9415292 Review.
Application of neural networks in structure-activity relationships.
Kövesdi I, Dominguez-Rodriguez MF, Orfi L, Náray-Szabó G, Varró A, Papp JG, Mátyus P. Kövesdi I, et al. Med Res Rev. 1999 May;19(3):249-69. doi: 10.1002/(sici)1098-1128(199905)19:3<249::aid-med4>3.0.co;2-0. Med Res Rev. 1999. PMID: 10232652 Review.
Targeted and shielded adenovectors for cancer therapy.
Hedley SJ, Chen J, Mountz JD, Li J, Curiel DT, Korokhov N, Kovesdi I. Hedley SJ, et al. Among authors: kovesdi i. Cancer Immunol Immunother. 2006 Nov;55(11):1412-9. doi: 10.1007/s00262-006-0158-2. Epub 2006 Apr 13. Cancer Immunol Immunother. 2006. PMID: 16612598 Review.
150 results